Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibody evasion by the P.1 strain of SARS-CoV-2

Cell(2021)10.1016/j.cell.2021.03.055Source: DataRank Database

Antibody evasion by the P.1 strain of SARS-CoV-2 is a research paper published in Cell (2021). On theSindex it has a DataRank of 12.0. It has been cited 662 times, with 200 citing works in its 1-hop citation network.

N/A

12.0DataRank · unranked

Scored on demand from live citation data

Open Access662 citations · 200 citing works in its network

Download PDF

Cite:

Linked data & code

gen cellosaurus nct pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (41 grants)OA: hybridTopics (72)IDs (PubMed, PMC)Annotations (5)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 8%Citation Network 92%

Base Score Contribution

0.975

From this paper's citation signal

Citation Network Contribution

11.1

From 200 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 200 citers.

BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced
Allergy202129 citations7 referencesContributes 0.486
SARS-CoV-2 Variants in Patients with Immunosuppression
New England Journal of Medicine2021477 citations14 referencesContributes 0.441
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019
The Journal of Infectious Diseases2021102 citations16 referencesContributes 0.290
COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
Cell2021142 citations20 referencesContributes 0.248
Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
Clinical Infectious Diseases202154 citations18 referencesContributes 0.223

Authors (50)

Daming Zhou ORCID,Piyada Supasa ORCID,Chang Liu ORCID,Alexander J. Mentzer ORCID,Helen M. Ginn ORCID

Live enrichment

PubMed:33852911 PMC:PMC8008340

Cancer Research UK Lincoln's Inn Fields Laboratories

Grant: C375/A17721

Chinese Academy of Medical Sciences and Peking Union Medical College

Grant: 2018-I2M-2-002

World Health Organization

Grant: PCT/GB2012/000467

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Grant: 403276/2020-9

National Institutes of Health

Grant: WT204969/Z/16/Z

National Institutes of Health

Grant: U19 I082360

Wellcome Trust

Grant: 203141/Z/16/Z

Wellcome Trust

Grant: 095541/A/11/Z

Wellcome Trust

Grant: 101122/Z/13/Z

Wellcome Trust

Grant: 090532/Z/09/Z

Medical Research Council

Grant: ACE2

Medical Research Council

Grant: MR/S007555/1

The Language of Zoonosis: Rationalising Receptor-Mediated Spillover of Viral Pathogens at a Molecular Level

Medical Research Council

Grant: MC_UU_00008/11

Medical Research Council

Grant: G1001046

Wellcome Trust

Grant: 109965/Z/15/Z

National Institute for Health Research (NIHR)

Grant: NIHR300791

Medical Research Council

Grant: MR/V001329/1

Wellcome Trust

Grant: 203224/Z/16/Z

Medical Research Council

Grant: G0600520

National Institute for Health Research (NIHR)

Grant: COV19OxfordVaccine01

Medical Research Council

Grant: MC_PC_19055

Medical Research Council

Grant: MR/N00065X/1

Structural Studies on Viruses, Viral Proteins and Cell Interactions

National Institute for Health Research (NIHR)

Grant: NF-SI-0515-10005

National Institute for Health Research (NIHR)

Grant: NF-SI-0617-10139

National Institute for Health Research (NIHR)

Grant: ACF-2018-13-005

National Institute for Health Research (NIHR)

Grant: CL-2018-13-007

Medical Research Council

Grant: MR/L018942/1

Wellcome Trust

Grant: 095541

Studies of immunopathogenesis in dengue virus infection.

Wellcome Trust

Grant: 101122

Improved control of endemic foot-and-mouth disease by development of virus like particle vaccines

Wellcome Trust

Grant: 090532

Understanding the genetic basis of common human diseases: core funding for the Wellcome Trust Centre for Human Genetics.

Wellcome Trust

Grant: 95541

Studies of immunopathogenesis in dengue virus infection.

Wellcome Trust

Grant: 203141

Human Genetics and Disease Biology: Core Renewal for the Wellcome Trust Centre for Human Genetics

Wellcome Trust

Grant: 204969

Characterising extreme innate immune response phenotypes informative for disease using a functional genomics approach

Public Health England

Fundação de Amparo à Pesquisa do Estado do Amazonas

UK Research and Innovation

National Institute for Health and Care Research

NIHR Oxford Biomedical Research Centre

Huo Family Foundation

Coalition for Epidemic Preparedness Innovations

National Institute for Health Research (NIHR)

hybridLicense: cc-by

publisherhttp://www.cell.com/article/S0092867421004281/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867421004281?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867421004281?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8008340

repositoryhttps://arca.fiocruz.br/handle/icict/47923

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

Cell LineHumansVaccinesAntibodies, MonoclonalAntibodies, ViralImmunization, PassiveVaccinationSequence DeletionBinding SitesProtein BindingMutationImmune EvasionAntibodies, NeutralizingSpike Glycoprotein, CoronavirusProtein DomainsCOVID-19SARS-CoV-2COVID-19 Serotherapy

Keywords

StructureVariantAntibodyNeutralizationspikeEscapeRbdSars-cov-2P.1Vh3-53Monoclonal antibodyCoronavirus Disease 2019 ResearchFOS: Health sciencesAntibodies, ViralPrediction of Peptide-MHC Binding AffinityArticleCell LineCoronavirus Disease 2019Binding siteProtein DomainsIn vitroBiochemistry, Genetics and Molecular BiologyVirologyImmunoglobulin light chainHealth SciencesGeneticsHumansMolecular BiologyBiologyCOVID-19 SerotherapyImmune EvasionSequence DeletionVaccinesBinding SitesVaccinationImmunization, PassiveAntibodies, MonoclonalCOVID-19Life SciencesStrain (injury)Neutralizing antibodyPotencyAntibodies, NeutralizingVirusInfectious DiseasesFOS: Biological sciencesMutationSpike Glycoprotein, CoronavirusMedicineAnatomyProtein Binding

Sustainable Development Goals

SDG 3: 3. Good health